Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 1/11/16  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Timothy J. Callahan

Wrong Dr. Timothy J. Callahan?

Chief Scientific Officer

Phone: (818) ***-****  
Email: t***@***.com
Local Address:  Los Angeles , California , United States
Biomedical Systems Corp
77 Progress Parkway Building One
Maryland Heights , Missouri 63043
United States

Company Description: Biomedical Systems offers our Sponsors flexible and responsive customization to their unique protocol needs. We have the ability to leverage our company-wide...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • PhD
  • Ph.D. , Interdisciplinary Studies with a concentration in Research Methodology
    Capella University
  • PhD.
80 Total References
Web References
People – Biomedical Systems
www.biomedsys.com, 28 Dec 2015 [cached]
Tim Callahan Chief Scientific Officer
...
Timothy Callahan, PhD
Chief Scientific Officer
Dr. Timothy Callahan has served as Biomedical Systems' Chief Scientific Officer since 2001 and brings over 25 years of clinical research expertise to the position including conducting research in Silent Myocardial Ischemia at the National Institutes of Health in Bethesda, Maryland. An expert in diagnostic testing, Dr. Callahan co-authored 2 patents in QT interval analysis and a patent in dynamical systems modeling of ECG data. He has authored many abstracts and publications as well as serving as the moderator for the past three FDA QT-IRT - ECG Core Lab meetings. Dr. Callahan received his Ph.D. from Capella University in Interdisciplinary Studies with a concentration in Research Methodology. He is a frequent speaker at Pharmaceutical Industry functions and sits on a number of advisory boards for peer reviewed publications.
Timothy J. Callahan ...
www.sec.gov, 11 Mar 2003 [cached]
Timothy J. Callahan (51)
Senior Vice President, Sales & Marketing
Senior Vice President, Sales and Marketing since September 2002.From 1999 to 2002, Mr. Callahan served as Senior Vice President, Distribution.Prior to that, Mr. Callahan was Regional Vice President, West from 1997 to 1999.Mr. Callahan has been with the company since 1997.
Firestone-Callahan & Associates
www.firestone-callahan.com, 11 Nov 2012 [cached]
Timothy J. Callahan, Principal
Mr. Callahan has 30 years of healthcare industry experience. He has a broad based understanding of peri-operative services, acute care and alternate site markets, as well as the market complexities facing industry stakeholders.
Prior to co-founding Firestone-Callahan & Associates, Mr. Callahan was president, chief operating officer, and a partner of SYMX Corporation, a global provider of medical equipment services and products utilizing advanced RFID technology.
He also spent 7 years with Owens & Minor, a fortune 500 company. During his tenure, his roles expanded to Sr. Vice President of Distribution as well as Sr. Vice President of Sales and Marketing. While helping drive business growth, his leadership introduced a unitized surgical delivery product, established a clinically focused specialties organization, and introduced a private label program to enhance margin and brand recognition.
Prior to Owens & Minor, Mr. Callahan was with Sterile Concepts, Inc., where he then served as the V.P. of Sales & Marketing until its acquisition by Maxxim Medical. He had expanded the sales organization from a manufacturing representative model to a blend of employed sales representatives. While at Sterile Concepts, Mr. Callahan participated in the acquisition of three companies and was part of the team responsible for taking the company public. Mr. Callahan came to Sterile Concepts through an acquisition of Harbor Medical, Inc. where he was a principal and Executive Vice President, producing custom procedure trays (CPT) for surgery in the southeast.
Before Sterile Concepts, Mr. Callahan was also a co-founder of Clinical Patient Services, Inc., providing acute care services and equipment to home care patients. As the company's President, he established the first licensed facility in the State of Florida for Prescribed Pediatric Extended Care (PPEC); providing comprehensive care to medically dependent children. Clinical Patient Services was acquired by Quest Medical, Inc.
Prior to CPS, Mr. Callahan was a partner in BimEco, Inc., a company providing advancing clinical technology for infusion therapy and vital signs monitoring to critical care, surgery and anesthesia areas. He began his career with American Hospital Supply.
Mr. Callahan holds a Bachelor of Science Degree in Business Administration from Marquette University. He has completed advanced executive education programs in finance and leadership from the Darden School of Business, University of Virginia and the University of Michigan.
People – Biomedical Systems
www.biomedsys.com, 24 May 2014 [cached]
Tim Callahan Chief Scientific Officer
Jay Winship Senior Medical Advisor
...
Timothy Callahan, PhD
Chief Scientific Officer
Dr. Timothy Callahan has served as Biomedical Systems' Chief Scientific Officer since 2001 and brings over 25 years of clinical research expertise to the position including conducting research in Silent Myocardial Ischemia at the National Institutes of Health in Bethesda, Maryland. An expert in diagnostic testing, Dr. Callahan co-authored 2 patents in QT interval analysis and a patent in dynamical systems modeling of ECG data. He has authored many abstracts and publications as well as serving as the moderator for the past three FDA QT-IRT - ECG Core Lab meetings. Dr. Callahan received his Ph.D. from Capella University in Interdisciplinary Studies with a concentration in Research Methodology. He is a frequent speaker at Pharmaceutical Industry functions and sits on a number of advisory boards for peer reviewed publications.
Biomedical Systems Expert Shares Insight on the Future of QT in Clinical Trials – Biomedical Systems
www.biomedsys.com, 6 Jan 2015 [cached]
(St. Louis; Jan. 06, 2015)- Timothy Callahan, Ph.D., chief scientific officer of Biomedical Systems, a premier, global provider of centralized diagnostic services, spoke on "Cardiac Safety in the Post E14 Era" at a recent seminar in Suzhou, China.
That information and his recent article in Applied Clinical Trials shed light on the future of QT in clinical trials in response to the FDA's indication that the thorough QT trial (TQT) will need to be replaced. The ICH guidance document E14, originally endorsed in 2005, covers the TQT trial.
"Regulatory agencies now expect a more broad-based cardiac safety dossier for new chemical entities," Callahan said, speaking at the 12th Annual Congress of International Drug Discovery Science & Technology (IDDST). "This will include both preclinical and clinical data to include variables such as blood pressure, heart rate and other ECG parameters beyond the QT interval."
An expert in diagnostic testing, Callahan suggests that shifting the burden of proof from a TQT trial to a combination of preclinical data and early phase human data might be beneficial. Callahan has more than 25 years of clinical research experience and has co-authored two patents in QT interval analysis and one in dynamical systems modeling of ECG data.
Other People with the name "Callahan":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.